U

United Therapeutics Corporation

Biotech company develops PAH therapies

Scientist – Tissue Engineering

Bioprocess & BiomanufacturingUpdated on Nov 12
Full-timeSilver Spring, MD, USA$111k - $147k

About the Job

Requirements

  • A Doctor of Philosophy (PhD) in life science or biomedical science is required.
  • At least 2 years of relevant pharmaceutical or academic research experience is required.
  • Prior experience in regenerative medicine, such as tissue engineering, decellularization, or biomaterials, is required.
  • Experience with laboratory instrumentation and data software is required.
  • The candidate must be able to organize and present data.
  • The candidate must be able to initiate and manage day-to-day tasks effectively.
  • Strong written and verbal scientific communication and presentation skills are required.
  • The candidate must be able to collaborate effectively in a fast-paced, highly interactive environment.

Responsibilities

  • Drive process optimization through experimental design, data analysis, and technology transfer while ensuring scientific rigor, accurate documentation, and alignment with regulatory and quality requirements.
  • Advance recellularization platforms from research and development through process characterization and clinical manufacturing readiness.
  • Lead, develop, and perform hands-on design, optimization, and execution of lung scaffold recellularization experiments using induced pluripotent stem cell (iPSC)-derived cells, and continuously improve recellularization methods.
  • Prepare organs, tissues, and cells for experimentation using appropriate surgical handling techniques, dissection, cannulation, and suturing.
  • Develop techniques, laboratory procedures, and protocols to support lung scaffold recellularization and characterization using iPSC-derived cells.
  • Develop strategies to seed multiple iPSC-derived cell types into lung scaffolds.
  • Evaluate vascular integrity, including vascular leak and blood perfusion, of lung tissues, native lungs, decellularized lung scaffolds, and tissue-engineered lung constructs.
  • Apply and adapt existing assays to evaluate cell phenotype and function on scaffolds recellularized with iPSC-derived cells.
  • Perform molecular and cell biology assays to evaluate cell distribution and phenotype in recellularized scaffolds.
  • Analyze and integrate data from multiple components of the recellularization process to draw conclusions and improve strategy development.
  • Coordinate shipment of samples for outsourced testing.
  • Maintain data integrity and laboratory operations by following Good Documentation Practices (GDP) and GLP-like standards, accurately recording data contemporaneously in in-house systems, and keeping the laboratory clean, organized, and safe.
  • Record and manage use of materials and reagents needed to carry out experiments.
  • Follow laboratory safety procedures, use personal protective equipment, and safely handle biohazard materials, including human or animal cells and tissues.
  • Supervise, lead, and mentor laboratory personnel and team members as required for specific tasks.
  • Collaborate with the iPSC production and differentiation team to align cell supply, quality, and timelines with recellularization needs, and with the process development team to adapt and optimize recellularization protocols for iPSC-derived cells.
  • Manage day-to-day laboratory operations, including housekeeping, inventory, ordering materials and reagents, and equipment upkeep.
  • Direct and manage direct reports, including training, goal setting and achievement, performance evaluations and management, coaching, mentoring, career development, and recruitment support as needed.
  • Perform other duties as assigned.

Desired Qualifications

  • Exposure to lung biology, lung physiology, pulmonary medicine, or respiratory therapy is preferred.

About the Company

United Therapeutics Corporation

Biotech company develops PAH therapies

United Therapeutics develops medicines for pulmonary arterial hypertension and other rare diseases, and pursues organ manufacturing through its Xenotransplantation efforts. Its drugs are given as oral tablets, intravenous infusions, or inhaled therapies to open damaged lung vessels and support heart function, while its organ programs aim to create bioengineered organs from donor animals to reduce rejection. The company differentiates itself by pairing a pharmaceutical portfolio with regenerative medicine and organ manufacturing, and by operating as a public-benefit corporation with sustainable facilities. Its goal is to end the organ transplant shortage by supplying transplantable organs while improving patient outcomes through better drug delivery and regenerative medicine.

Company size
Not listed
Company stage
IPO
Headquarters
Silver Spring, MD
Founded
1996

Recently Posted Jobs

Explore more opportunities at United Therapeutics Corporation

See more jobs